Organoid model: A new hope for pancreatic cancer treatment?

Biochim Biophys Acta Rev Cancer. 2021 Jan;1875(1):188466. doi: 10.1016/j.bbcan.2020.188466. Epub 2020 Nov 4.

Abstract

Pancreatic cancer is a rapidly progressing disease with a poor prognosis. We still have many questions about the pathogenesis, early diagnosis and precise treatment of this disease. Organoids, a rapidly emerging technology, can simulate the characteristics of pancreatic tumors. Using the organoid model of pancreatic cancer, we can study and explore the characteristics of pancreatic cancer, thereby effectively guiding clinical practice and improving patient prognosis. This review introduces the development of organoids, comparisons of organoids with other preclinical models and the status of organoids in basic research and clinical applications for pancreatic cancer.

Keywords: Application; Development; Future; Organoid; Pancreatic tumor.

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Organoids / drug effects*
  • Pancreas / drug effects
  • Pancreatic Neoplasms / drug therapy
  • Pancreatic Neoplasms / genetics*
  • Pancreatic Neoplasms / pathology
  • Precision Medicine*
  • Prognosis

Substances

  • Antineoplastic Agents